Antibiotic resistance and its cost: is it possible to reverse resistance?

被引:1604
作者
Andersson, Dan I. [1 ]
Hughes, Diarmaid [2 ]
机构
[1] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden
[2] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden
基金
瑞典研究理事会;
关键词
FUSIDIC ACID RESISTANCE; ENTERICA SEROVAR TYPHIMURIUM; BETA-LACTAMASE INDUCTION; GROUP-A STREPTOCOCCI; IN-VIVO FITNESS; STAPHYLOCOCCUS-AUREUS; DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; BIOLOGICAL COST;
D O I
10.1038/nrmicro2319
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Most antibiotic resistance mechanisms are associated with a fitness cost that is typically observed as a reduced bacterial growth rate. The magnitude of this cost is the main biological parameter that influences the rate of development of resistance, the stability of the resistance and the rate at which the resistance might decrease if antibiotic use were reduced. These findings suggest that the fitness costs of resistance will allow susceptible bacteria to outcompete resistant bacteria if the selective pressure from antibiotics is reduced. Unfortunately, the available data suggest that the rate of reversibility will be slow at the community level. Here, we review the factors that influence the fitness costs of antibiotic resistance, the ways by which bacteria can reduce these costs and the possibility of exploiting them.
引用
收藏
页码:260 / 271
页数:12
相关论文
共 141 条
[1]   Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus:: a time-series analysis [J].
Aldeyab, Mamoon A. ;
Monnet, Dominique L. ;
Maria Lopez-Lozano, Jose ;
Hughes, Carmel M. ;
Scott, Michael G. ;
Kearney, Mary P. ;
Magee, Fidelma A. ;
McElnay, James C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (03) :593-600
[2]   Gene Amplification and Adaptive Evolution in Bacteria [J].
Andersson, Dan I. ;
Hughes, Diarmaid .
ANNUAL REVIEW OF GENETICS, 2009, 43 :167-195
[3]   The biological cost of antibiotic resistance [J].
Andersson, DI ;
Levin, BR .
CURRENT OPINION IN MICROBIOLOGY, 1999, 2 (05) :489-493
[4]   Clonal spread of resistant pneumococci despite diminished antimicrobial use [J].
Arason, VA ;
Gunnlaugsson, A ;
Sigurdsson, JA ;
Erlendsdottir, H ;
Gudmundsson, S ;
Kristinsson, KG .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2002, 8 (03) :187-192
[5]   THE VANS-VANR 2-COMPONENT REGULATORY SYSTEM CONTROLS SYNTHESIS OF DEPSIPEPTIDE PEPTIDOGLYCAN PRECURSORS IN ENTEROCOCCUS-FAECIUM BM4147 [J].
ARTHUR, M ;
MOLINAS, C ;
COURVALIN, P .
JOURNAL OF BACTERIOLOGY, 1992, 174 (08) :2582-2591
[6]   Glycopeptide resistance in enterococci [J].
Arthur, M ;
Reynolds, P ;
Courvalin, P .
TRENDS IN MICROBIOLOGY, 1996, 4 (10) :401-407
[7]   Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models [J].
Austin, DJ ;
Anderson, RM .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1384) :721-738
[8]   Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs [J].
Austin, DJ ;
Bonten, MJM ;
Weinstein, RA ;
Slaughter, S ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6908-6913
[9]   Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man [J].
Bean, DC ;
Livermore, DM ;
Papa, I ;
Hall, LMC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (05) :962-964
[10]   Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001 [J].
Bergman, M ;
Huikko, S ;
Pihlajamäki, M ;
Laippala, P ;
Palva, E ;
Huovinen, P ;
Seppälä, H .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) :1251-1256